GlassScriptPhysician profile
Kathleen Garrett
NPI 1760782890
$2,982.55
in general payments reported to CMS, 2019-2025
20 companies · $678 in 2025
The $678 reported for 2025 was more than what 97% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $277 · 2022: $507 · 2023: $743 · 2024: $777 · 2025: $678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,198.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $490.35 | 2021-2025 | |
| Astellas Pharma US INC | $353.65 | 2022-2025 | Veozah |
| Abbvie INC. | $271.26 | 2021-2023 | |
| Exeltis, USA INC. | $236.70 | 2021-2025 | Slynd, Twirla |
| Sage Therapeutics, LLC | $234.54 | 2023-2025 | Zurzuvae |
| Novo Nordisk INC | $231.11 | 2023-2025 | Wegovy |
| Sumitomo Pharma America, INC. | $211.42 | 2023-2025 | Myfembree |
| Daiichi Sankyo INC. | $204.33 | 2021-2024 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $156.08 | 2021-2025 | |
| Bard Peripheral Vascular, INC. | $145.58 | 2024 | Venovo |
| Myovant Sciences INC. | $93.47 | 2021-2022 | |
| Organon LLC | $85.02 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $81.92 | 2021-2024 | Gardasil 9, Gardasil |
| Shield Therapeutics INC | $52.53 | 2023-2025 | Accrufer |
| Pfizer INC. | $42.61 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $28.35 | 2025 | Myosure Tissue Removal Device |
| Millicent US INC | $24.82 | 2025 | Intrarosa, Femlyv |
| Scynexis, INC. | $13.96 | 2022 | |
| Evofem Biosciences, INC. | $12.63 | 2021 | |
| Smith+Nephew, INC. | $12.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Garrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.